TruScreen Group Limited (NZE:TRU)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0330
-0.0010 (-2.94%)
Feb 28, 2025, 4:59 PM NZST
50.00%
Market Cap 18.24M
Revenue (ttm) 2.68M
Net Income (ttm) -1.83M
Shares Out 552.59M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 239,106
Average Volume 303,343
Open 0.0340
Previous Close 0.0340
Day's Range 0.0330 - 0.0340
52-Week Range 0.0150 - 0.0370
Beta -0.05
RSI 71.47
Earnings Date Feb 27, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. T... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Country New Zealand
Stock Exchange New Zealand Stock Exchange
Ticker Symbol TRU
Full Company Profile

Financial Performance

In 2023, TruScreen Group's revenue was 2.60 million, an increase of 25.18% compared to the previous year's 2.08 million. Losses were -2.05 million, -14.63% less than in 2022.

Financial Statements

News

There is no news available yet.